You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Citation Tools

Article menu
Emerging technologies, pharmacology and therapeutics
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pratley RE, Jacob S, Baek S, et al
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
BMJ Open Diabetes Research and Care 2022;10:e002207. doi: 10.1136/bmjdrc-2021-002207